In the joint PANTHER project, Fraunhofer MEVIS is working on using CT images more effectively in tumor therapy follow-ups.
What effect does a particular cancer medicine or radiation therapy have on patients? To find out, physicians use CT images to determine whether a tumor’s size changes during the course of treatment. In the PANTHER project, a joint team of experts aims at gaining further valuable information from these images.
In the future, doctors will be able to find out at an early stage whether a cancer treatment is effective or should be changed. The Fraunhofer Institute for Medical Image Computing MEVIS, with its branches in Bremen and Lübeck, is an essential project partner. This spring, the project team will present the interim results from the first project period.
Physicians monitor the course of tumor therapy by observing the general condition of their patients, analyzing lab values from blood tests, and taking regular CT images of the affected organs. Until now, doctors have only used the images to monitor tumor size development. Has the tumor shrunk as a result of radiation or chemotherapy or has it grown further, making a change in therapy, such as choosing an alternative medication, seem reasonable?
This is where the joint PANTHER project comes into play. “So far, size development of a tumor is the most important criterion in evaluating CT images,” says Fraunhofer MEVIS computer scientist Jan Hendrik Moltz.
“Yet, there is so much more information hidden in these images that has barely been used.” In addition to size progression, the images also show how and to which degree the shape of the ulcer has changed. They can give details about the texture and nature of the tumor, whether it consists of different types of tissues, and whether its composition changes during the course of therapy.
Much of this information is invisible to the naked eye, which causes difficulties. “To be able to recognize and in particular quantify these features, physicians need computer assistance,” says Moltz. “This is precisely the goal of PANTHER.”
Since October 2016, the Federal Ministry of Education and Research has sponsored the joint “Patient-oriented oncological therapy assistance” project with an overall funding around 2.8 million euro. In addition to Fraunhofer MEVIS, further participants include the Medical Center of the University of Munich, MeVis BreastCare GmbH & Co.KG, as well as project coordinator Siemens Healthcare GmbH.
In the first phase, radiologists of the Medical Center of the University of Munich compiled large amounts of CT image data of colon cancer and lymphoma patients. The clinicians segmented relevant structures in the images using a web tool, making the size and shape of the tumors and organs in the images recognizable and measurable. At a later stage, an automatic algorithm will perform the segmentation instead.
The oncologists in Munich provided extensive data material on patients’ response to a therapy and how their blood values changed during the course of treatment. Experts want to align particular features of the CT images with the data, such as changes in the shape and texture of the tumor during therapy. Comprehensive statistical analyses will reveal possible reliable correlations between image and therapy data. “Ideally, the CT images would help assess at an early stage whether or not a particular therapy is successful,” says Julian Holch, an oncologist at the Medical Center of the University of Munich.
Soon, the PANTHER team will be preparing for a mid-term review. “We have already collected a large share of the data and developed essential parts of the software, for example, for the automatic segmentation of the spleen,” explains Moltz. “We have also identified features in the CT images that we wish to evaluate with statistical analyses.” For patients with colon cancer, change in liver metastases could be a possible indicator of therapy success. For lymphoma patients, changes in spleen shape could deliver clues concerning the effect of therapy.
“By the end of the project in 2019, the potential benefit of our approach for medicine should be clear,” says Jan Hendrik Moltz. “The next step would be the development of a computer-based expert system that supports doctors in choosing the best therapy.”
The joint project is an example of a new approach in medicine called radiomics, a mix of radiology and genomics. Elaborate algorithms could help extract additional information from radiological images and correlate them with data from clinics and labs. The goal is to develop therapies that target specific patients or cancer types. “Radiomics has the potential of making medicine more efficient and thus produce benefits for the patients,” says Horst Hahn, one of Fraunhofer MEVIS’ directors. “This way, we can gain profound analysis of diseases that can help figure out which patients will respond to what therapy methods.”
Bianka Hofmann | Fraunhofer MEVIS - Institut für Bildgestützte Medizin
Stroke therapy - study shows positive effects of Urokinase
10.12.2019 | Universitätsspital Bern
'Virtual biopsy' allows doctors to accurately diagnose precancerous pancreatic cysts
06.12.2019 | Ohio State University Wexner Medical Center
More than one hundred and fifty years have passed since the publication of James Clerk Maxwell's "A Dynamical Theory of the Electromagnetic Field" (1865). What would our lives be without this publication?
It is difficult to imagine, as this treatise revolutionized our fundamental understanding of electric fields, magnetic fields, and light. The twenty original...
In a joint experimental and theoretical work performed at the Heidelberg Max Planck Institute for Nuclear Physics, an international team of physicists detected for the first time an orbital crossing in the highly charged ion Pr⁹⁺. Optical spectra were recorded employing an electron beam ion trap and analysed with the aid of atomic structure calculations. A proposed nHz-wide transition has been identified and its energy was determined with high precision. Theory predicts a very high sensitivity to new physics and extremely low susceptibility to external perturbations for this “clock line” making it a unique candidate for proposed precision studies.
Laser spectroscopy of neutral atoms and singly charged ions has reached astonishing precision by merit of a chain of technological advances during the past...
The ability to investigate the dynamics of single particle at the nano-scale and femtosecond level remained an unfathomed dream for years. It was not until the dawn of the 21st century that nanotechnology and femtoscience gradually merged together and the first ultrafast microscopy of individual quantum dots (QDs) and molecules was accomplished.
Ultrafast microscopy studies entirely rely on detecting nanoparticles or single molecules with luminescence techniques, which require efficient emitters to...
Graphene, a two-dimensional structure made of carbon, is a material with excellent mechanical, electronic and optical properties. However, it did not seem suitable for magnetic applications. Together with international partners, Empa researchers have now succeeded in synthesizing a unique nanographene predicted in the 1970s, which conclusively demonstrates that carbon in very specific forms has magnetic properties that could permit future spintronic applications. The results have just been published in the renowned journal Nature Nanotechnology.
Depending on the shape and orientation of their edges, graphene nanostructures (also known as nanographenes) can have very different properties – for example,...
Using a clever technique that causes unruly crystals of iron selenide to snap into alignment, Rice University physicists have drawn a detailed map that reveals...
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
12.12.2019 | Physics and Astronomy
12.12.2019 | Physics and Astronomy
12.12.2019 | Life Sciences